Novo Nordisk Reports Positive STEP Young Phase 3 Data
Bagsværd, Denmark — September 7, 2026 Novo Nordisk announced positive first results from the STEP Young Phase 3 trial,...
Novo Nordisk
Advertisement
Novo Nordisk Launches Once-Weekly Awiqli in the U.S.
Plainsboro, New Jersey, August,11, 2026 Novo Nordisk has announced the nationwide U.S. launch of Awiqli® (insulin icodec-abae) injection 700...
Novo Nordisk and AWS Partner to Accelerate AI Drug Discovery
Bagsværd, Denmark, August 10, 2026 Novo Nordisk and Amazon Web Services (AWS) announced a strategic partnership aimed at accelerating...
Scholar Rock Advances Apitegromab FDA Review with Second Fill-Finish Facility
CAMBRIDGE, Mass., August 7, 2026 Scholar Rock announced that the U.S. Food and Drug Administration (FDA) review of its...
Vivani Medical Completes Phase 1 SLIM-1 Dosing of NPM-139 Implant
ALAMEDA, Calif., August 6, 2026 Vivani Medical, Inc. announced the successful full enrollment and initial dosing of all 20...
Advertisements
UCB Reports FINTEPLA Study Showing Sustained LGS Benefits
Atlanta, Georgia, August 5, 2026 UCB has announced the publication of a post hoc analysis in Epilepsia Open demonstrating...
Novo Nordisk Wins Dutch Injunction Over Semaglutide Spray
Bagsværd, Denmark, August 5, 2026 Novo Nordisk has secured a significant legal victory after the District Court of The...
Novo Nordisk Reports ZEUS Phase 3 Results for Ziltivekimab
BAGSVÆRD, Denmark, July 31, 2026 Novo Nordisk announced headline results from the Phase 3 ZEUS cardiovascular outcomes trial evaluating...
Novo Nordisk Secures EU Approval for Oral Wegovy
BAGSVÆRD, Denmark, July 15, 2026 Novo Nordisk has achieved a major regulatory milestone after the European Commission (EC) granted...
Helix Expands Drug Discovery Collaboration with AstraZeneca
SAN MATEO, Calif., July 7, 2026 Helix has announced a multi-year strategic agreement with AstraZeneca to accelerate genomic research,...
Advertisement
